Static
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
First reported by Ars Technica ·
The signal
●○○○
Brief pending · reported by Ars Technica, the single source so far
Source description shown. AI brief pending.
Moderna